Send us Fan Mail

How close is pathology AI to making decisions that matter in real workflows, real trials, and real patient care?

In this episode of DigiPath Digest, I review five recent papers that approach that question from very different angles. We look at multimodal survival prediction in cervical cancer, pathology-driven response assessment in neoadjuvant immunotherapy for head and neck squamous cell carcinoma, AI-assisted Ki-67 scoring in pulmonary neuroendocrine neoplasms, automation and AI in hematologic diagnostics, and AI-based qFibrosis readouts from the Phase 3 MAESTRO-NASH trial.

What I liked about this set of papers is that they do not all tell the same story. Some show clear progress. Some show where AI already works well as an adjunct. Others make it very clear that validation, governance, reproducibility, and workflow design still matter just as much as model performance.

Key topics and timestamps

• 00:00 Introduction, Easter edition, and community updates
• 00:51 USCAP recap, signed book giveaway, and free Digital Pathology 101 PDF
• 02:04 Partnerships, lab automation preview, and what’s coming in this episode
• 03:25 Multimodal deep learning for cervical cancer survival prediction
• 13:00 Why pathology may be a better response endpoint than radiology in neoadjuvant HNSCC immunotherapy
• 23:09 Ki-67 scoring in pulmonary neuroendocrine neoplasms: pathologists vs two AI systems
• 33:46 AI, digital morphology, and automation in hematologic diagnostics
• 43:29 qFibrosis, digital biomarkers, and the MAESTRO-NASH Phase 3 trial
• 51:57 Closing thoughts, community updates, and Easter promotion

Resources

1. Deep Learning Can Predict the Overall Survival of Cervical Cancer Based on Histopathological Image, Gene Mutation and Clinical Information
   https://pubmed.ncbi.nlm.nih.gov/41902378/
   
   
2. Modern Pathology-Driven Strategies in Neoadjuvant Immunotherapy for Head and Neck Squamous Cell Carcinoma: From Residual Tumor Quantification to Spatial and AI-Based Biomarkers
   https://pubmed.ncbi.nlm.nih.gov/41899621/
   
   
3. Ki-67 Proliferation Index in Pulmonary Neuroendocrine Neoplasms: Interobserver Agreement Among Pathologists and Comparison of Two Artificial Intelligence-Based Image Analysis Systems
   https://pubmed.ncbi.nlm.nih.gov/41898274/
   
   
4. Molecular Pathology, Artificial Intelligence, and New Technologies in Hematologic Diagnostics: Translational Opportunities and Practical Considerations
   https://pubmed.ncbi.nlm.nih.gov/41897649/
   
   
5. Quantitative regression of qFibrosis with resmetirom: Exploratory histologic endpoints from the MAESTRO-NASH phase III clinical trial
   https://pubmed.ncbi.nlm.nih.gov/41895606/

Support the show

Get the "Digital Pathology 101" FREE E-book and join us!

Send us Fan Mail

Why do digital pathology projects get harder once the real workflow starts?

In this USCAP 2026 conversation, I talk with Robert Moody from Hamamatsu and Jake Eden from Agilent about what the conference theme, MAKING CONNECTIONS, looks like in actual digital pathology implementation. This was not just a conversation about products. It was a conversation about workflow. We talked about why consistent staining matters before scanning, why strong partnerships need a shared vision, and why labs increasingly want a simpler point of contact as they move into digital pathology.

One point I really liked is that the value of a partnership is no longer just in combining components. It is in reducing complexity for the lab. Robert and Jake explain how vendors increasingly act as guides during digital transformation, helping customers navigate technical decisions, implementation steps, and the many stakeholders involved beyond pathology itself. That includes IT, information security, legal, finance, and lab operations.

Another key theme is that no two deployments look the same. Some labs are centralized. Some are hub-and-spoke. Some outsource parts of the workflow. That is why future-proofing came up so strongly in this episode. Jake talks about keeping options open with open, agnostic workflows, and Robert makes the practical point that the most expensive thing you can do is the same implementation twice.

Key highlights

• [00:22] Why this episode moves from high-level partnerships to what they look like in the lab
• [02:33] Why staining consistency matters for successful digital workflows
• [03:14] Shared vision, relationships, and why partnerships start with people
• [05:29] The idea of a single point of contact to reduce complexity for labs
• [08:32] Why vendors have become digital pathology guides
• [10:03] Why every deployment is unique
• [14:22] Future-proofing and choosing open, agnostic workflows
• [15:46] Why doing the same implementation twice is the expensive mistake to avoid

Support the show

Get the "Digital Pathology 101" FREE E-book and join us!

Send us Fan Mail

Why does digital pathology adoption move faster in some places than others?

In this USCAP 2026 conversation, I sat down with Robert Moody and Fumiya Fuji from Hamamatsu to talk about what the conference theme, MAKING CONNECTIONS, really looks like in practice. This was not just a scanner conversation. It was a workflow conversation.

We talked about why digital pathology has shifted from a scanner-first mindset to a solution-first one, and why that matters for labs trying to build workflows that actually work. Robert explained why partnerships now need to happen earlier, with software, hardware, and execution teams involved from the start. Fumiya added a global perspective, comparing adoption drivers across the US, Japan, Europe, and Canada, and explaining why local support systems, ROI, geography, and government backing can all change the pace of adoption.

One point I especially liked was this: digital pathology is not one product. It is an ecosystem. And if one component fails, the whole workflow can break down. That is why connected thinking matters so much right now. This episode is really about how companies, labs, and partners are learning to work more like a team.

Key highlights

• [00:00] Why MAKING CONNECTIONS fits digital pathology so well
• [01:37] Why partnerships matter beyond the scanner
• [04:29] The shift from scanner-first to solution-first
• [04:58] How adoption differs across the US, Japan, Europe, and Canada
• [09:01] Why global collaboration inside Hamamatsu matters
• [10:50] How partnerships move from paper to real-world execution
• [12:55] Why does the USCAP show floor show a more connected industry
• [14:37] Why the next phase of digital pathology depends on interoperability and connected workflows

Support the show

Get the "Digital Pathology 101" FREE E-book and join us!